Rheumatoid Arthritis
Conditions
Interventions
investigational material(s)
Generic name etc : T-614 50 mg
INN of investigational material :
Therapeutic category code : 399 Agents affecting metabolism, n.e.c.
Dosage and Administration for Investig
Sponsors
Toyama Chemical Co., Ltd.(Current FUJIFILM Toyama Chemical Co., Ltd.)
Eisai Co., Ltd.
Eligibility
Sex/Gender
All
Inclusion criteria
Inclusion criteria: The study population consist of subjects with active RA. Key inclusion criteria are as follows: 1)Patients provided written informed consent and were aged greater or 20 years and less than 70 years old 2)Patients had a diagnosis of active RA for less than 10 years, based on American College of Rheumatology (ACR) criteria.
Exclusion criteria
Exclusion criteria: Key exclusion criteria are as follows: 1)Steinbrocker's class IV. 2)Patients have the complication and anamnesis, different inflammatory joint disease from RA, a malignant tumor, or HIV. 3)Women of childbearing potential who are not practicing a successful method of contraception, or wish to become pregnant.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Efficacy and safety Efficacy and safety | — |
Outcome results
None listed